Diagnosis and Management of Epileptic Encephalopathies in Children

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Structural/metabolic</td><td align="center"> </td></tr><tr><td align="left"> Pre-, peri-, and postnatal cerebral ischemia</td><td align="center"> </td></tr><tr><td align="left"> Cerebral malformations</td><td align="center"> </td></tr><tr><td align="left"> Neuro-infections sequalae</td><td align="center"> </td></tr><tr><td align="left"> Neurocutaneous syndromes: tuberous sclerosis, incontinentia pigmenti</td><td align="center"> </td></tr><tr><td align="left"> Hypothalamic hamartoma</td><td align="center"> </td></tr><tr><td align="left"> Inborn errors of metabolism: biotinidase deficiency and other organic aciduria, phenylketonuria, mitochondrial disorders,  Menkes disease, nonketotic hyperglycinemia, and antiquitin deficiency </td><td align="center"> </td></tr><tr><td align="left">Genetic</td><td align="center"> </td></tr><tr><td align="left"> Genetic: CDKL-5, MeCP 2, ARX, STXBP-1, SPTAN1, and PLC-<i>β</i>1</td><td align="center"> </td></tr><tr><td align="left"> Chromosomal disorders: down syndrome, 1p36 deletion, and Pallister-Killian syndrome</td><td align="center"> </td></tr><tr><td align="left">Unknown</td><td align="center"> </td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Epilepsy Research and Treatment

tab3

Table 3

Table 3: Diagnosis and Management of Epileptic Encephalopathies in Children 